Journal of Research in Pharmacy Practice最新文献

{"title":"Consumer's Satisfaction with Community Pharmacies in Sindh, Pakistan.","authors":"Yun Jin Kim, Muhammad Shahzad Aslam, Syed Muhammad Fahim, Waris Ali Khan, Linchao Qian","doi":"10.4103/jrpp.JRPP_20_108","DOIUrl":"10.4103/jrpp.JRPP_20_108","url":null,"abstract":"<p><strong>Objective: </strong>The present research is the first comprehensive cross-sectional study of consumer satisfaction with community pharmacies in Sindh, Pakistan. Moreover, the study has also designed a nonorder theoretical model for consumer satisfaction with community pharmacies.</p><p><strong>Methods: </strong>This is a cross-sectional descriptive study from a general population of Sindh, Pakistan, with a total of four hundred and fifteen (<i>n</i> = 415) participants. A confirmatory factor analysis was used to verify the factor structure between Pharmaceutical services (PS), the Skill of Pharmacists, Non-pharmaceutical services (NPS), and pricing (P). Pearson correlation analysis, Kendall's tau correlation analysis, and Spearman's rho correlation analysis were used to identify the correlation between different factors, such as PS, SKP, NPS, and P.</p><p><strong>Findings: </strong>The 23-item scale that consisted of four elements have shown an acceptable root mean squared error of approximation (0.076), Cronbach's alpha (0.787), and Chi-square value (3.381) (<i>P</i> < 0.001). Of the respondents, 56.4% rated their satisfaction on pharmacist attitude, whereas 67.2%, 41.4%, and 51.8% were satisfied with other services, such as receipt provided on medication they take, prescription drug service and availability of pharmacies on the weekend and public holidays, respectively.</p><p><strong>Conclusion: </strong>This cross-sectional study confirms that there are relationships among PS, SPK, NPS, and P. Moreover, there is a lack of facilities in community pharmacies in Sindh, such as the unavailability of a consultation room, immunization services, information on routine health matters, and medication record.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"78-82"},"PeriodicalIF":0.8,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/99/JRPP-10-78.PMC8420935.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial.","authors":"Harsh Durgia,&nbsp;Sadishkumar Kamalanathan,&nbsp;Govindarajalou Ramkumar,&nbsp;Sonali Sarkar,&nbsp;Sagili Vihaya Bhaskar Reddy,&nbsp;Jayaprakash Sahoo,&nbsp;Rajan Palui,&nbsp;Henith Raj","doi":"10.4103/jrpp.JRPP_20_130","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_130","url":null,"abstract":"<p><strong>Objective: </strong>The primary purpose was to compare the effect of 2 mg and 4 mg of intravenous zoledronic acid (ZA) on change in the lumbar spine (LS) bone mineral density (BMD) at the end of 1 year in postmenopausal women with osteoporosis. The secondary objectives were changes in BMD at the total hip and femoral neck, change in bone turnover markers (BTMs), and the incidence of new fractures.</p><p><strong>Methods: </strong>This was a double-blind, parallel-arm, randomized control trial with an allocation ratio of 1:1 done in 70 postmenopausal women with osteoporosis.</p><p><strong>Findings: </strong>The mean (±standard deviation) percentage increase in LS BMD at the end of 1 year was 4.86% ± 3.05% and 5.35% ± 3.73% in the 2 mg and 4 mg group, respectively. The dose of 2 mg ZA proved to be inferior to 4 mg with a noninferiority margin of 0.5%. There was no difference in BMD change at hip and BTMs between the two groups at the end of 1 year. Only one patient in 4 mg group developed two new vertebral fractures during a 12-month follow-up. Acute-phase reactions were the most common (43%) side-effects noted without any difference between the two groups (<i>P</i> = 0.63).</p><p><strong>Conclusion: </strong>This study failed to show the noninferiority of 2 mg ZA compared to 4 mg ZA for change in LS BMD at the end of 1 year.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"71-77"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/97/JRPP-10-71.PMC8420937.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of the Combination of Indomethacin and Methocarbamol versus Indomethacin Alone in Patients with Acute Low Back Pain: A Double-Blind, Randomized Placebo-Controlled Clinical Trial.","authors":"Shiva Samsamshariat,&nbsp;Mehdi Sharifi-Sade,&nbsp;Shafeajafar Zoofaghari,&nbsp;Asieh Maghami Mehr,&nbsp;Ali Mohammad Sabzghabaee","doi":"10.4103/jrpp.JRPP_21_31","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_31","url":null,"abstract":"<p><strong>Objective: </strong>Acute low back pain is a common ailment and causes pain and disability. Physicians often prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) to treat acute low back pain; however, due attention has recently been drawn to muscle relaxants to reduce the severity of patients' daily physical dysfunction. Therefore, this study aimed to evaluate the therapeutic effect of the administration of indomethacin alone compared with methocarbamolas a muscle relaxant and indomethacin as an NSAID on the treatment of acute low back pain.</p><p><strong>Methods: </strong>The present double-blind clinical trial was performed on 64 patients with acute low back pain. The patients were categorized into two groups and received the treatments as follows. Indomethacin capsules of 25 mg every 8 h and placebo tablets every 8 h were administered in the first group (Group I). Indomethacin capsules of 25 mg every 8 h and methocarbamol tablets of 500 mg every 8 h were administered in the second group (Group I + M). Patient pain intensity and physical function based on Back Pain Function Scale (BPFS) were recorded before and 1 week after the intervention.</p><p><strong>Findings: </strong>The present study results revealed that the mean pain reduction of patients in Group I + M was significantly higher than that of Group I (3.66 ± 3.17 vs. 1.84 ± 1.53; <i>P</i> < 0.001). Moreover, the mean BPFS increase in Group I + M was significantly higher than that of Group I (19.44 ± 8.66 vs. 4.75 ± 4.35; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>According to the results of the present study, concomitant administration of indomethacin and methocarbamol can be more effective in reducing pain intensity and improving the patient's physical function (or performance).</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"96-101"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/ae/JRPP-10-96.PMC8420930.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment Methods and Competency Mapping in Pharmacy Education: Understanding of Components and Quality Parameters.","authors":"Syed Wasif Gillani,&nbsp;Kishore Gnana Sam,&nbsp;Fithawit Bahran Gebreigziabher,&nbsp;Jumana Al-Salloum,&nbsp;Rizah Anwar Assadi,&nbsp;Shabaz Mohiuddin Gulam","doi":"10.4103/jrpp.JRPP_21_29","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_29","url":null,"abstract":"<p><p>Centre of advanced pharmaceutical education have developed 15 subsets of competencies required to be competent pharmacist and able to provide optimum care. These competencies were further categorized; Level 1 intermediate, Level 2 efficient, and Level 3 professional. These competencies are cross-mapped to achieve desirable outcomes. Where personal and professional development skills incorporate knowledge, for being a holistic pharmacist. In healthcare education curriculums, active learning tools such as simulation-based patient cases and other innovative learning activities are used to teach clinical skills, patient assessments, and pharmacotherapy concepts. The advance team-based learning technique for the development of stepwise understanding of disease management (simple-complex cases) and students can communicate and collaborate for the critical thinking and decision-making process. Many studies showed the positive impact of the peer teaching on the students; enhanced their academic performance, increase the cognitive congruence, and allows the students to share their own learning struggles to come up with solutions to overcome these challenges. Pharmacy is a healthcare professional required intensive training and professional skills to provide optimum care to patients. The emerging clinical role of pharmacy focused on the patient-centered model, comprehensive assessment, and teaching methods are required to fulfill the professional competencies.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"102-105"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/0a/JRPP-10-102.PMC8420934.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Pattern of Medication Usage in the Southern Region of Iran: A population-based Pharmacoepidemiological Study.","authors":"Marziyeh Zare,&nbsp;Saba Afifi,&nbsp;Amir Hossein Alizadeh Bahmani,&nbsp;Iman Karimzadeh,&nbsp;Mohammad Salehi-Marzijarani,&nbsp;Leila Zarei,&nbsp;Behnam Honarvar,&nbsp;Sulmaz Ghahremani,&nbsp;Kamran B Lankarani,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Payam Peymani","doi":"10.4103/jrpp.JRPP_21_5","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_5","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to document the demographic data, to assess the proportion of consumed medicines and the amounts and types of drugs available to households, and to to estimate the probable prevalence of certain diseases in the southern region of Iran.</p><p><strong>Methods: </strong>In this cross-sectional population-based study carried out in Shiraz (the central city in the Southern part of Iran), we documented and evaluated the drug usage details in a random sample of 1000 households during 2018-2020. We analyzed the usage of drug categories based on the anatomical therapeutic chemical classification, which the World Health Organization recommends.</p><p><strong>Findings: </strong>In the studied population, the average age (± standard deviation) was 45.54 ± 15.82, ranged 18-91 years. More than 90% had medical insurance coverage. About 81.8% of the participants had individual family medicine practitioners, and most of them (93.8%) received medications with a physician's prescription. The most frequently used medications were cough and cold preparations (12.9%), nervous system drugs (12.6%), and cardiovascular system drugs (11.6%).</p><p><strong>Conclusion: </strong>Despite the easy access to medications for most participants, few individuals (about 6%) received their medications without a prescription. The most frequently prescribed medicines were the common cold, acetaminophen, and metformin. Common cold, gastrointestinal (GI) disorder, and diabetes were the most commonly used medication classes. Furthermore, we have found a probably higher than average prevalence of cardiovascular, GI, and endocrine disorders. This information could be used by the local policymakers as a basis for the estimation and allotment of health-care resources.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"83-89"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/c3/JRPP-10-83.PMC8420931.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing the Performance of Community Pharmacies in Iran by Measuring Responsiveness to Non-Medical Needs: An Application of WHO Responsiveness Framework.","authors":"Saba Afifi,&nbsp;Amir Hossein Alizadeh Bahmani,&nbsp;Leila Zarei,&nbsp;Motahareh Mahi-Birjand,&nbsp;Mehdi Hoorang,&nbsp;Marziyeh Zare,&nbsp;Iman Karimzadeh,&nbsp;Farzad Peiravian,&nbsp;Mahtabalsadat Mirjalili,&nbsp;Payam Peymani","doi":"10.4103/jrpp.JRPP_21_23","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_23","url":null,"abstract":"<p><strong>Objective: </strong>Despite growing debates about the health systems' nonmedical performance, there has not been any empirical research on nonmedical performance and patients' rights consideration as a driver of human rights in the pharmaceutical sector. This study's main objective was to assess the nonmedical performance of community pharmacies of Shiraz, Iran.</p><p><strong>Methods: </strong>A cross-sectional study was conducted using two self-administrated Likert-based questionnaires based on the World Health Organization (WHO) responsiveness framework and the legal charter communicated by the Ministry of Health and Medical Education of Iran. The population was patients older than 18 years who took a prescription from community pharmacies located in Shiraz and willing to answer the questions voluntarily, from 2018 to 2019. Considering the weights of subdimensions of responsiveness provided by the WHO framework, the total score of responsiveness was calculated ranging from 0 to 100.</p><p><strong>Findings: </strong>The response rate was 80.5%. The mean (standard deviation) overall score of responsiveness was 57.18 (21.61), with a median of 56.71. The mean score of client orientation was lower in respondents with a high education level than those with a diploma and under diploma (<i>P</i> = 0.028).</p><p><strong>Conclusion: </strong>Nonmedical pharmacy performance was considered either medium or high in more than half of the cases based on the participants' views. Regarding client, orientation was seen less often in patients with high education level compared to those with a lower education level.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"59-64"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/e2/JRPP-10-59.PMC8420932.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metabolic Acidosis in Multi Drug Poisoning with Antidepressants and Antipsychotics.","authors":"Nastaran Eizadi-Mood,&nbsp;Saba Dehghanzad,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Ziba Farajzadegan","doi":"10.4103/jrpp.JRPP_20_106","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_106","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we evaluated the predictive factors for the occurrence of metabolic acidosis in patients with multi-drug poisoning, including antidepressants (Ad)/antipsychotics (Ap).</p><p><strong>Methods: </strong>This cross-sectional study was carried out in the referral poisoning center, Khorshid University Hospital, affiliated with Isfahan University of Medical Sciences. All patients with multi-drug ingestion, including Ad/Ap, were included in the study. Patients were divided into two groups with and without metabolic acidosis. Demographic factors, time from ingestion to admission, clinical manifestations, length of hospital stay, and outcome were compared in two groups. Binary logistic regression was used to identify factors associated with the risk of metabolic acidosis occurrence.</p><p><strong>Findings: </strong>Among the 206 evaluated patients, 45 patients (21.8%) had metabolic acidosis whom the majority were female (73.3%) with intentional purposes (77.8%). 31.1% of the patients with metabolic acidosis had tachycardia on admission (<i>P</i> = 0.03). Among all variables, time from ingestion to admission (<i>P</i> = 0.02) and lengths of hospital stay (<i>P</i> = 0.002) were significantly different between patients with and without metabolic acidosis. Tachycardia on admission (adjusted odds ratio [OR], 2.24; 95% confidence interval [CI]: 1.05-4.76; <i>P</i> = 0.036) and time from ingestion to admission (adjusted OR, 1.06; 95% CI: 1.00-1.13; <i>P</i> = 0.04) were also the predictive factors in occurrence of metabolic acidosis. Most of the patients survived without any complications (94.6%), of whom 72.3% had no previous underlying somatic diseases (<i>P</i> = 0.05).</p><p><strong>Conclusion: </strong>Admission tachycardia and the time elapsed from ingestion to admission may be considered important factors for predicting metabolic acidosis in multi-drug poisoning, including Ad/Ap.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 2","pages":"65-70"},"PeriodicalIF":1.0,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/9a/JRPP-10-65.PMC8420936.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39420453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adherence to Lipid-Lowering Medication in People Living with HIV: An Outpatient Clinic Drug Direct Distribution Experience.","authors":"Gianluca Cuomo,&nbsp;Alessandro Raimondi,&nbsp;Marianna Rivasi,&nbsp;Giovanni Guaraldi,&nbsp;Vanni Borghi,&nbsp;Cristina Mussini","doi":"10.4103/jrpp.JRPP_20_96","DOIUrl":"10.4103/jrpp.JRPP_20_96","url":null,"abstract":"<p><strong>Objective: </strong>Adherence to lipid-lowering drugs could be challenging in our patients as it is in the general population, which is described as low as 25%. Our aim was to evaluate adherence to statins and to investigate clinical event impact on it.</p><p><strong>Methods: </strong>This retrospective study on HIV+ patients attending to Clinic of Modena (Italy) was conducted in order to evaluate characteristics, clinical events, and adherence on lipid-lowering drugs. All drugs for comorbidities are distributed by the hospital pharmacy and recorded in an electronical database. Adherence was also evaluated in patients who were supplied with antilipemics in external pharmacies through phone calls. Patients were considered adherent if the percentage of correct time of drug refill was >80%.</p><p><strong>Findings: </strong>Totally 1123 patients were evaluated. Lipid-lowering drugs (statins, fenofibrate, and omega-3 oil) were prescribed in 242 patients (21.5%). Prescription occurred mainly in those who were older, males, and Italians. Two hundred of them (82.6%) used statins alone, 23 (9.5%) only fenofibrate or omega-3 oil, and 19 (7.8%) a combination of both drugs. The median adherence was 90% while patients with adherence >80% resulted 153 (63.2%). Forty-six (19%) had a clinical history of cardiovascular events; 59% of them, placed in secondary prophylaxis, and 76%, already in treatment, continued to adhere. No differences in terms of adherence according to the type of drug distribution (hospital pharmacy or outside pharmacies) were found.</p><p><strong>Conclusion: </strong>Linking the supply of these drugs to that of antiretrovirals led to a good level of adherence higher than that described in the general population. The majority of the patients who experienced a cardiovascular event remain adherent to the prescribed therapy.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"10-16"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/b1/JRPP-10-10.PMC8259599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria.","authors":"Mainul Haque,&nbsp;Abdullahi Rabiu Abubakar,&nbsp;Olayinka O Ogunleye,&nbsp;Ibrahim Haruna Sani,&nbsp;Israel Sefah,&nbsp;Amanj Kurdi,&nbsp;Salequl Islam,&nbsp;Brian Godman","doi":"10.4103/jrpp.JRPP_20_92","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_20_92","url":null,"abstract":"<p><strong>Objective: </strong>Measures are ongoing to prevent the spread of COVID-19 and treat it with medicines and personal protective equipment (PPE). However, there has been considerable controversy surrounding treatments such as hydroxychloroquine with misinformation fuelling prices hikes and suicides. Shortages have also appreciably increased costs of PPE, potentially catastrophic among lower- and middle-income countries such as Nigeria with high copayment levels. Consequently, a need to investigate changes in availability, utilization, and prices of relevant medicines and PPE during the pandemic in Nigeria.</p><p><strong>Methods: </strong>Exploratory study among community pharmacists with a survey tool comprising four sections including questions on changes in consumption, prices, and shortages of medicines and PPE from the beginning of March 2020 to the end of June 2020. In addition, suggestions from community pharmacists and co-authors on ways to reduce misinformation.</p><p><strong>Findings: </strong>30 out of 34 pharmacists participated giving a response rate of 88.2%. Significant increases were seen (3-fold or more increase) in the consumption of hydroxychloroquine (100%), vitamins/immune boosters (96.7%) and antibiotics (46.7%) as well as PPE (100%). Considerable price increases (50% increase or greater) also seen for antimalarials (96.7%), antibiotics (93.3%), vitamins/immune boosters (66.7%), and PPE (100%). Shortages are also seen for hydroxychloroquine and vitamins/immune boosters but most severe for PPE (80% of pharmacies).</p><p><strong>Conclusion: </strong>Encouraging to see increases in the utilization of vitamins/immune boosters and PPE. However, a considerable increase in the utilization and prices of antimicrobials is a concern that needs addressing including misinformation. Community pharmacists have a key role in providing evidence-based advice and helping moderate prices.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"17-22"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/a5/JRPP-10-17.PMC8259594.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Safety and Effectiveness of Pharmacotherapy for Opioid-Overdose Induced Aspiration Pneumonia in a Referral Poisoning Management University Hospital in Iran.","authors":"Mohammadreza Tabatabaei,&nbsp;Gholamali Dorvashy,&nbsp;Rasoul Soltani,&nbsp;Shiva Samsamshariat,&nbsp;Rokhsareh Meamar,&nbsp;Ali Mohammad Sabzghabaee","doi":"10.4103/jrpp.JRPP_21_17","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_17","url":null,"abstract":"<p><strong>Objective: </strong>Opioid abuse is widespread throughout the world. Aspiration pneumonia is a serious problem following opioid overdose and poisoning. This study aimed to evaluate the safety and effectiveness of antimicrobial management of opioid-overdose induced aspiration pneumonia in a referral poisoning management university hospital in Iran.</p><p><strong>Methods: </strong>In an observational cross-sectional study (September-March 2019), opioid poisoned patients diagnosed with aspiration pneumonia within a maximum of 48 h of their overdose were evaluated regarding several variables, including the level of consciousness on admission, drug regimen used for the treatment of aspiration pneumonia, and its appropriateness, and the correctness of the used antibiotics dose and the therapeutic outcome.</p><p><strong>Findings: </strong>During the study, 53 eligible patients were identified and included in the study. The most frequently abused opioids were methadone (60.4%) and opium (17%). \"Ceftriaxone + Clindamycin\" (54.7%) and \"Meropenem + Vancomycin\" (9.5%) were the most frequently administered regimens. Regarding treatment outcome, most cases (<i>n</i> = 36, 67.9%) were discharged with a stable and satisfying medical status, while 3.8% of the cases (<i>n</i> = 2) died.</p><p><strong>Conclusion: </strong>The use of antibiotics in the treatment of aspiration pneumonia in hospitalized patients with opioid overdose in our referral university hospital is associated with notable antibiotic regimen choice issues. The implementation of strategies for improving the pattern of antibiotic prescribing for these patients is necessary.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 1","pages":"38-42"},"PeriodicalIF":1.0,"publicationDate":"2021-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/08/JRPP-10-38.PMC8259600.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39210680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}